Kopmar NE, Gooley T, Curley N, Russell K, et al. Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms. Leuk Lymphoma 2023;64:1057-1059.
PMID: 36896478